Changes in the content of protein and lipid oxidative modification products in tumor tissue at different stages of lung cancer.
The content of LPO products (conjugated dienes, MDA) and products of oxidative modification of proteins (protein carbonyl derivatives) is reduced in tumor tissue in comparison with normal tissue and varies depending on the disease stage.